Fig. 3

Hematoxilin and Eosin section of colorectal adenocarcinoma with zone delineated for microdissection prior to molecular KRAS testing with 70% neoplastic cells
Hematoxilin and Eosin section of colorectal adenocarcinoma with zone delineated for microdissection prior to molecular KRAS testing with 70% neoplastic cells